DiscoverThe Top LineESMO, WCLC lung cancer data spark hope—and debate
ESMO, WCLC lung cancer data spark hope—and debate

ESMO, WCLC lung cancer data spark hope—and debate

Update: 2024-09-27
Share

Description

At the recent World Conference on Lung Cancer and European Society for Medical Oncology annual meetings, two packages of lung cancer data from a partnership between Akeso and Summit Therapeutics and another collaboration between iTeos Therapeutics and GSK showed much promise of disrupting the current standard of care. But they also drew some questions and debate. 

In this week's episode of “The Top Line,” Angus Liu from Fierce Pharma and Gabrielle Masson from Fierce Biotech discuss the key issues behind those two readouts.   

To learn more about the topic in this episode: 

See omnystudio.com/listener for privacy information.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ESMO, WCLC lung cancer data spark hope—and debate

ESMO, WCLC lung cancer data spark hope—and debate

Fierce Life Sciences